US healthcare giant Johnson & Johnson and three major distributors, AmerisourceBergen, Cardinal Health and McKesson, have finalized a long-negotiated nationwide...

As wealthy countries with ample supplies of Covid-19 vaccine struggle to convince more people to get the shot, and poorer countries struggle to nail down supplies, two US...

Another US healthcare business is being split into separate parts or separated from other parts of a diverse group. First General Electric, with its health segment, went...

South Africa's Aspen Pharmacare aims to ramp up its Covid-19 vaccine manufacturing capacity to 1.3 billion doses per year by February 2024, from 250 to 300 million doses...

As expected, Johnson & Johnson is taking its spun-off baby powder business into bankruptcy as a means of sidestepping a steadily moving avalanche of lawsuits claiming...

Janssen Sciences Ireland, the pharmaceutical and biotechnology arm of US healthcare giant Johnson & Johnson, has submitted a planning application for a €150 million...

Doses of Johnson & Johnson’s Covid-19 vaccine made at Aspen Pharmacare’s facility in South Africa and shipped to Europe to fill contractual obligations will now be sent...

Alex Gorsky, chairman and CEO of Johnson & Johnson since 2012, has announced he will step down from the healthcare giant’s top slot at the beginning of 2022 and hand over...